2019
DOI: 10.1101/688564
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Single-cell RNA sequencing reveals mRNA splice isoform switching during kidney development

Abstract: During mammalian kidney development, nephron progenitors undergo a mesenchymal to epithelial transition and eventually differentiate into the various tubular segments of the nephron. Recently, the different cell types in the developing kidney were characterized using the Dropseq single cell RNA sequencing technology for measuring gene expression from thousands of individual cells. However, many genes can also be alternatively spliced and this creates an additional layer of heterogeneity. We therefore used full… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
9
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(12 citation statements)
references
References 63 publications
(8 reference statements)
3
9
0
Order By: Relevance
“…Compared to other reports identifying specific targets of ESRPs using RNA-seq (58, 59), we found several targets in common, including well-known genes such as CD44, CTNND1, SCRIB and SLK , as well as over 600 genes that had not been previously described as ESRP2 targets (figure 7C). An additional comparison with a recent study of MET-associated alternative splicing changes during kidney development (60) also revealed overlap with some of our target genes (figure 7D). Interestingly, the two lists of genes identified in figures 7C and D as overlapping our ESRP2 targets, included five genes in common ( CTNND1, CTTN, FLNB, MAO3K7, MPRIP ; shown in bold in figures 7C and D).…”
Section: Resultssupporting
confidence: 59%
See 1 more Smart Citation
“…Compared to other reports identifying specific targets of ESRPs using RNA-seq (58, 59), we found several targets in common, including well-known genes such as CD44, CTNND1, SCRIB and SLK , as well as over 600 genes that had not been previously described as ESRP2 targets (figure 7C). An additional comparison with a recent study of MET-associated alternative splicing changes during kidney development (60) also revealed overlap with some of our target genes (figure 7D). Interestingly, the two lists of genes identified in figures 7C and D as overlapping our ESRP2 targets, included five genes in common ( CTNND1, CTTN, FLNB, MAO3K7, MPRIP ; shown in bold in figures 7C and D).…”
Section: Resultssupporting
confidence: 59%
“…D: Venn diagram comparing unique genes identified in this study (SE+MXE+RI) with a RNA-seq analysis of MET-associated splicing changes in the developing kidney (60). …”
Section: Resultsmentioning
confidence: 99%
“…Ideally, the best way to characterize alternative splicing throughout the different developmental stages is by applying full transcript length single-cell RNA sequencing [42][43][44][45]. We have recently performed full transcript length single-cell RNA sequencing in the developing mouse fetal kidney [46] and identified a set of transcripts -similar to those found here -that undergo splice isoform switching during the transition between mesenchymal and epithelial cellular states that takes place in the course of mouse fetal kidney development. Likewise, RNA binding motif enrichment analysis suggested that Esrp1/2 and Rbfox1/2 are splicing regulators of the Mesenchymal to Epithelial Transition (MET) that occurs during mouse kidney development, also similar to what we found here.…”
Section: Discussionmentioning
confidence: 62%
“…They are likely to be useful for a wide number of future applications. Another important aspect of these data is that it adds information on alternative splicing differences along the renal tubule, adding to other recent evidence 70 . We believe these data together with previous RNA-seq 17 and more recent proteomic data 61 from rat tubules will enhance our understanding of renal function.…”
Section: Discussionmentioning
confidence: 81%